Present status of clofibrate in Canada.
作者信息
Lucis O J
出版信息
Can Med Assoc J. 1981 Aug 15;125(4):346-8.
Abstract
摘要
相似文献
1
Present status of clofibrate in Canada.氯贝丁酯在加拿大的现状。
Can Med Assoc J. 1981 Aug 15;125(4):346-8.
2
[Clofibrate therapy--the status quo].
Z Gesamte Inn Med. 1982 Jan 15;37(2):59-63.
3
[Current studies on antilipemic agents].[当前关于抗脂药的研究]
Nihon Rinsho. 1975 Nov 10;33(11):3205-10.
4
Five-year trial of clofibrate in ischaemic heart disease.
Br Heart J. 1971 Jan;33(1):145.
5
Serious adverse effects with clofibrate.氯贝丁酯的严重不良反应。
N Z Med J. 1980 Oct 22;92(670):315-6.
6
Influence of treatment adherence in the coronary drug project.
N Engl J Med. 1981 Mar 5;304(10):612-3. doi: 10.1056/NEJM198103053041018.
7
[Clofibrate--more harm than good?].[氯贝丁酯——弊大于利？]
Duodecim. 1979;95(3):97-9.
8
Trial of clofibrate.氯贝丁酯试验。
Br Med J. 1972 Feb 19;1(5798):506. doi: 10.1136/bmj.1.5798.506-a.
9
[Clofibrate in coronary diseases].[氯贝丁酯与冠状动脉疾病]
Tidsskr Nor Laegeforen. 1975 Dec 10;95(34-36):1987-8.
10
[Clofibrate--overreaction?].
Duodecim. 1979;95(14-15):875-7.
本文引用的文献
1
Mechanism of the hypolipemic effect of clofibrate in glucose-fed men.氯贝丁酯对葡萄糖喂养男性的降血脂作用机制。
Metabolism. 1980 Mar;29(3):279-88. doi: 10.1016/0026-0495(80)90070-0.
2
High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs.降血脂治疗期间的高密度脂蛋白。四种药物的比较研究。
Atherosclerosis. 1980 Mar;35(3):215-28. doi: 10.1016/0021-9150(80)90121-5.
3
Clofibrate and hyperlipidaemia.氯贝丁酯与高脂血症
Lancet. 1980 Dec 6;2(8206):1241. doi: 10.1016/s0140-6736(80)92493-9.
4
Clofibrate in coronary heart disease. Effect on morbidity and mortality.
JAMA. 1972 Feb 14;219(7):845-51.
5
Effects of clofibrate on cholesterol metabolism.氯贝丁酯对胆固醇代谢的影响。
Clin Pharmacol Ther. 1977 Aug;22(2):154-63. doi: 10.1002/cpt1977222154.
6
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.在动脉粥样硬化疾病患者中，联合降脂治疗可显著降低脂蛋白脂质水平。
Atherosclerosis. 1979 Aug;33(4):457-77. doi: 10.1016/0021-9150(79)90038-8.
Zotero 插件